As of Jan 17
| +0.67 / +0.95%|
The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 69.00, with a high estimate of 77.00 and a low estimate of 64.00. The median estimate represents a -2.80% decrease from the last price of 70.99.
The current consensus among 3 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.